+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bio-based Isododecane Market by Application (Cosmetics, Industrial Solvents, Lubricants), Purity Grade (Cosmetic Grade, Industrial Grade, Pharmaceutical Grade), End User, Sales Channel, Feedstock Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6121717
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Bio-based isododecane has rapidly evolved from a niche green solvent to a cornerstone of modern formulation design, driven by escalating sustainability mandates and consumer demand for cleaner ingredients. By deriving isododecane from renewable feedstocks rather than petroleum, stakeholders gain environmental benefits while preserving the superior performance characteristics that have made this branched-chain hydrocarbon invaluable across multiple end markets. As a low-viscosity, nonpolar fluid with high spreadability and quick evaporation, it addresses critical formulation challenges in cosmetics, industrial applications, and beyond.

Amid tightening regulatory landscapes and heightened scrutiny of petrochemical residues, renewable isododecane offers a compelling alternative that aligns with circular economy principles. Major manufacturers are collaborating with agricultural producers to secure traceable supply chains, while research teams are optimizing biocatalytic pathways to improve yield efficiency and reduce energy consumption. Furthermore, its odorless profile and low toxicity have facilitated adoption in sensitive applications such as topical pharmaceuticals and inhalation products.

Looking ahead, this shift from conventional to bio-based isododecane is set to accelerate, propelled by advancements in fermentation technologies and novel feedstock diversification. Stakeholders who understand these dynamics and invest in scalable production infrastructure will be well positioned to capitalize on an expanding landscape of eco-conscious consumers and increasingly rigorous regulatory frameworks.

Exploration of Dynamic Disruptions in Bio-based Isododecane Production, Regulatory Reforms, and Sustainability Innovations Transforming Market Structures

The bio-based isododecane ecosystem is undergoing a series of dynamic disruptions that are redefining cost structures, supply chain resilience, and product innovation potential. First, breakthroughs in enzymatic catalysis and strain engineering have significantly improved the conversion efficiency of plant-derived sugars into high-purity hydrocarbon streams, lowering production costs and enhancing scalability. At the same time, lifecycle analysis frameworks are becoming more sophisticated, enabling formulators to quantify carbon footprints with greater precision and communicate verifiable sustainability credentials to end customers.

Moreover, regulatory reforms in major markets such as the European Union are introducing stricter thresholds for residual solvents in personal care products, promoting the gradual phaseout of non-renewable alternatives. This regulatory momentum is complemented by consumer-driven subscription platforms that demand transparency and third-party verification of environmental claims. In response, leading producers are forging strategic partnerships that integrate traceability protocols into smart contracts, ensuring real-time visibility across the value chain. Additionally, venture capital inflows into green chemistry startups have accelerated, creating a vibrant innovation pipeline that spans nanoscale reactor design, continuous flow processing, and waste valorization.

Consequently, the landscape is shifting from a supplier-centric model to a more collaborative innovation network. Companies that foster open innovation ecosystems and align incentives across farming co-operatives, catalyst developers, and formulation houses will capture disproportionate value as the sector matures.

In-depth Analysis of How Newly Proposed United States Tariffs for 2025 Reshape Trade Flows, Supply Chains, and Competitiveness in Bio-based Isododecane

The introduction of proposed United States tariffs on bio-based isododecane imports slated for 2025 has introduced a pivotal inflection point for global supply chains. While the stated goal of the tariff framework is to protect domestic renewable chemical manufacturing, the cascading effects are already prompting companies to reassess sourcing strategies. Raw material flows from traditional feedstock regions are under renewed scrutiny, leading to negotiations for long-term contracts that incorporate tariff escalation clauses and conditional volume commitments.

Parallel to these protective measures, trading partners have signaled intent to lodge dispute challenges through international bodies, creating uncertainty around the final structure of duties and potential retaliatory measures. In anticipation, industry players are diversifying procurement by establishing dual-source channels, including in-country production facilities and bonded warehouse arrangements that optimize cash flow under duty suspension programs. tion. As a result, cost management is evolving from a static exercise in price negotiation to a dynamic approach that integrates tariff hedging instruments and scenario-based supply chain simulations.

Furthermore, manufacturers of value-added isododecane derivatives are expanding process capabilities closer to end markets to mitigate cross-border friction. This trend is reinforced by contract research organizations offering toll manufacturing services in low-tariff jurisdictions, enabling rapid scale-up of specialty grades without incurring punitive duties. Ultimately, stakeholders who build adaptive logistics infrastructures and leverage digital trade compliance tools will navigate the unfolding tariff landscape with greater agility and competitive advantage.

Holistic Insights into Market Segmentation by Application, Purity Grade, End User, Sales Channels, and Feedstock Types Guiding Strategic Positioning

Understanding the nuances of heterogeneous demand requires a granular exploration of bio-based isododecane segmentation based on application. Within personal care formulations, renewable isododecane is most prominently utilized in foundation systems for its light texture and quick-drying profile. Formulators are also incorporating it into lipsticks to achieve a silky finish that resists feathering, and into moisturizers to enhance emollience without greasiness. In industrial settings, it serves as a high-purity cleaning fluid for precision components and as a low-odor solvent in specialty coatings that must meet stringent emissions standards. Additionally, the lubricant sector is bifurcating into bio-lubricants that deliver biodegradability and metalworking fluids that require stable viscosity under extreme thermal loads. The pharmaceutical domain is likewise segmenting, with inhalation-grade solvents optimized for respirable particle formation and topical-grade solvents calibrated for dermatological safety.

Purity grade delineation further refines positioning, with cosmetic grade meeting trace-level residual specifications, industrial grade balancing cost and performance, and pharmaceutical grade exceeding pharmacopeial thresholds for toxicity and microbial content. End user considerations cut across these tiers, distinguishing between heavy industrial operations prioritizing throughput efficiency, personal care brands demanding sensory excellence, and pharmaceutical companies focused on regulatory compliance.

Sales channel complexity arises from direct contracts tied to strategic alliances, distributor partnerships that offer regional reach and technical support, and burgeoning online platforms enabling formulators to procure small-volume specialty grades. Feedstock variety underpins all of these dimensions, as manufacturers optimize production around corn-based ethanol streams in North America, palm-derived intermediates in Southeast Asia, and sugarcane-sourced biowaxes in tropical regions. This multi-layered segmentation framework empowers decision-makers to align product offerings with the precise performance, cost, and sustainability criteria of each sector.

Strategic Examination of Regional Dynamics Across Americas, Europe Middle East Africa, and Asia Pacific Driving Bio-based Isododecane Adoption and Growth

The Americas continue to lead in renewable isododecane adoption through a blend of robust feedstock availability and progressive regulatory incentives for low-carbon chemistry. North American producers benefit from established corn ethanol infrastructure, facilitating back integration into hydrocarbon synthesis. Moreover, the personal care industry in the United States and Canada has established eco-labeling programs that accelerate commercial acceptance. Meanwhile, corporate investment into demonstration plants in South America is expanding capacity for sugarcane-derived production, unlocking new volume streams and fostering cross-border collaboration on sustainability standards.

In Europe, the Middle East, and Africa, the landscape is characterized by a mosaic of regulatory regimes and feedstock endowments. The European Union’s Green Deal and Renewable Energy Directive have set ambitious decarbonization targets, driving formulators to source certified renewable inputs. Simultaneously, North African nations are forging partnerships to export palm biomass and date-palm residues for isododecane manufacturing, while Middle Eastern petrochemical hubs are trialing captive production facilities to diversify beyond fossil-derived products. This regional heterogeneity necessitates tailored go-to-market approaches that account for divergent incentive structures and local content requirements.

Asia-Pacific represents a dynamic frontier where rapid cosmetic penetration in markets such as China, South Korea, and Japan is fueling demand for lightweight, non-greasy emollients. Local producers are investing heavily in bioprocessing R&D to tap abundant sugarcane and palm oil feedstocks, while Southeast Asian governments are implementing sustainability certification frameworks to guard against deforestation. These concerted efforts are creating a virtuous cycle of capacity expansion and knowledge transfer, positioning the region as a critical growth catalyst for the global bio-based isododecane supply chain.

Detailed Profile of Key Industry Players, Competitive Strategies, Innovation Pipelines, and Collaboration Networks Shaping Bio-based Isododecane Market Leadership

A small cohort of chemical manufacturers and specialty firms now exerts outsized influence on the evolution of renewable isododecane, leveraging proprietary technologies and integrated supply chains to secure competitive moats. Some established global chemical suppliers have retrofitted existing hydrocarbon cracking units to process biomass-derived intermediates, thus reducing capital expenditure and accelerating time to market. Others have forged joint ventures with agribusiness conglomerates to lock in large-scale feedstock commitments, enabling them to offer multi-year price guarantees that appeal to risk-averse formulators.

Meanwhile, agile biotech startups are driving innovation through modular reactor platforms that reduce biomass pretreatment and purification steps. By partnering with innovation centers and universities, these ventures gain access to advanced enzymatic toolkits and high-throughput screening capabilities, advancing novel pathways that could substantially lower production costs. At the same time, contract manufacturing organizations are expanding into toll processing of sustainable solvents, offering brownfield assets in strategic locales to minimize capital outlays for new product entrants.

On the commercialization front, specialty distributors and digital marketplaces are collaborating with research laboratories to streamline product sampling and technical support. These alliances are enhancing end-user engagement by providing formulation trials, performance benchmarking, and regulatory dossiers in a single integrated service package. Collectively, these differentiated approaches to technology development, supply chain integration, and customer enablement are defining the competitive battleground for bio-based isododecane market leadership.

Actionable Roadmap for Industry Leaders Emphasizing Operational Agility, Strategic Partnerships, and Sustainability Practices to Capitalize on Emerging Opportunities

To thrive in this rapidly evolving arena, industry leaders should prioritize the development of flexible production architectures that accommodate multiple feedstocks and adjust to tariff and policy shifts. Investing in modular process units not only minimizes downtime during feedstock transitions but also allows for incremental capacity expansion aligned with demand signals. Equally important is the cultivation of strategic partnerships spanning agricultural cooperatives, catalyst providers, and logistics specialists to enhance raw material security and negotiate favorable procurement terms.

In parallel, companies must deepen their engagement with regulatory bodies and standard-setting organizations to influence emerging guidelines around green solvents and sustainability certifications. Active participation in technical working groups not only secures early visibility into policy changes but also positions firms as thought leaders advancing best practices. Furthermore, adopting digital supply chain platforms that integrate blockchain-based traceability can bolster transparency and differentiate offerings in increasingly discerning end markets.

Finally, organizations should embrace collaborative innovation models, such as pre-competitive consortia and open innovation challenges, to accelerate the development of next-generation biocatalytic processes and recycling protocols. By co-investing in pilot facilities and leveraging shared infrastructure, stakeholders can mitigate individual risk while collectively advancing the commercial readiness of transformative technologies. These coordinated actions will foster operational resilience, sustain market momentum, and establish a foundation for long-term, sustainable growth.

Transparent Methodological Framework Employing Multisource Primary and Secondary Research, Expert Consultations, and Rigorous Data Validation for Market Insights

This analysis draws upon a rigorous blend of primary and secondary research methodologies to ensure comprehensive, objective, and verifiable insights. In the primary phase, in-depth interviews were conducted with senior executives, process engineers, and product managers across leading chemical manufacturers, biotech innovators, and end-user formulators. These conversations provided first-hand perspectives on technological bottlenecks, regulatory hurdles, and go-to-market strategies.

Concurrently, secondary research encompassed the systematic review of technical journals, patent filings, white papers, and government policy documents. Extensive data extraction from reputable industry databases and environmental lifecycle assessments further informed feedstock cost comparisons and sustainability benchmarking. Data triangulation techniques were applied to cross-validate qualitative inputs with secondary findings, ensuring that observed trends reflect both empirical evidence and expert judgment.

To enhance data integrity, a multi-tier validation process was implemented, involving peer reviews by subject matter specialists and follow-up queries with interviewees to clarify ambiguities. Where discrepancies arose, supplementary documentation from certification bodies and industrial symposia presentations was consulted. The resulting research framework delivers high-confidence insights that enable stakeholders to navigate the complex bio-based isododecane landscape with clarity and strategic foresight.

Concise Synthesis of Core Findings, Emerging Trends, and Strategic Imperatives for Stakeholders Navigating the Future of Bio-based Isododecane

Throughout this executive summary, the convergence of sustainable feedstock innovation, regulatory evolution, and strategic collaboration has emerged as the defining narrative driving bio-based isododecane’s ascent. From advanced enzymatic processes that elevate production efficiency to region-specific policy incentives that accelerate commercial uptake, the industry is transitioning toward a more resilient and transparent value chain.

Moreover, the layered segmentation by application, purity grade, end user, sales channel, and feedstock type underscores the importance of targeted strategies aligned with performance criteria and sustainability mandates. Whether serving the fastidious formulation needs of cosmetic brands or meeting the throughput demands of industrial users, stakeholders must tailor their offerings to specific market imperatives.

Looking ahead, agile players who invest in feedstock diversification, digital traceability, and joint innovation will capture disproportionate value. A proactive approach to navigating tariff uncertainties and regulatory shifts will further solidify competitive positioning. Ultimately, the collaborative ethos among technology providers, agricultural partners, and end users will define success in a landscape where environmental stewardship and profitability converge.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cosmetics
      • Foundation
      • Lipstick
      • Moisturizer
    • Industrial Solvents
      • Cleaning
      • Coatings
    • Lubricants
      • Bio-Lubricants
      • Metalworking Fluids
    • Pharmaceuticals
      • Inhalation Solvents
      • Topical Solvents
  • Purity Grade
    • Cosmetic Grade
    • Industrial Grade
    • Pharmaceutical Grade
  • End User
    • Industrial
    • Personal Care
    • Pharma
  • Sales Channel
    • Direct
    • Distributor
    • Online
  • Feedstock Type
    • Corn
    • Palm
    • Sugarcane
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Evonik Industries AG
  • Croda International Plc
  • Clariant AG
  • Dow Inc.
  • BASF SE
  • Solvay S.A.
  • Inolex Chemical Company
  • Arkema S.A.
  • Koster Keunen, Inc.
  • Symrise AG

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Major cosmetic manufacturers accelerating adoption of bio-based isododecane for sustainable makeup formulations
5.2. Advances in microbial fermentation processes enabling scalable bio-based isododecane production at lower cost
5.3. Partnerships between startup biotechs and global suppliers to secure eco-friendly isododecane feedstock supply chains
5.4. Regulatory shift in Europe and North America incentivizing replacement of petroleum isododecane with renewable alternatives
5.5. Lifecycle assessment findings demonstrating significantly reduced carbon footprint of bio-based isododecane across industries
5.6. Development of high-purity bio-based isododecane grades tailored for precision cleaning in electronics manufacturing
5.7. Integration of circular economy principles in bio-based isododecane production through feedstock waste valorization strategies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bio-based Isododecane Market, by Application
8.1. Introduction
8.2. Cosmetics
8.2.1. Foundation
8.2.2. Lipstick
8.2.3. Moisturizer
8.3. Industrial Solvents
8.3.1. Cleaning
8.3.2. Coatings
8.4. Lubricants
8.4.1. Bio-Lubricants
8.4.2. Metalworking Fluids
8.5. Pharmaceuticals
8.5.1. Inhalation Solvents
8.5.2. Topical Solvents
9. Bio-based Isododecane Market, by Purity Grade
9.1. Introduction
9.2. Cosmetic Grade
9.3. Industrial Grade
9.4. Pharmaceutical Grade
10. Bio-based Isododecane Market, by End User
10.1. Introduction
10.2. Industrial
10.3. Personal Care
10.4. Pharma
11. Bio-based Isododecane Market, by Sales Channel
11.1. Introduction
11.2. Direct
11.3. Distributor
11.4. Online
12. Bio-based Isododecane Market, by Feedstock Type
12.1. Introduction
12.2. Corn
12.3. Palm
12.4. Sugarcane
13. Americas Bio-based Isododecane Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Bio-based Isododecane Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Bio-based Isododecane Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Evonik Industries AG
16.3.2. Croda International Plc
16.3.3. Clariant AG
16.3.4. Dow Inc.
16.3.5. BASF SE
16.3.6. Solvay S.A.
16.3.7. Inolex Chemical Company
16.3.8. Arkema S.A.
16.3.9. Koster Keunen, Inc.
16.3.10. Symrise AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIO-BASED ISODODECANE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIO-BASED ISODODECANE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIO-BASED ISODODECANE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BIO-BASED ISODODECANE MARKET: RESEARCHAI
FIGURE 26. BIO-BASED ISODODECANE MARKET: RESEARCHSTATISTICS
FIGURE 27. BIO-BASED ISODODECANE MARKET: RESEARCHCONTACTS
FIGURE 28. BIO-BASED ISODODECANE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIO-BASED ISODODECANE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FOUNDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FOUNDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LIPSTICK, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LIPSTICK, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY MOISTURIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY MOISTURIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CLEANING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CLEANING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COATINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COATINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY BIO-LUBRICANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY BIO-LUBRICANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY METALWORKING FLUIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY METALWORKING FLUIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INHALATION SOLVENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INHALATION SOLVENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY TOPICAL SOLVENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY TOPICAL SOLVENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETIC GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETIC GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PERSONAL CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CORN, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CORN, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PALM, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PALM, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SUGARCANE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SUGARCANE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 120. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 121. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 122. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 123. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 124. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 125. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 126. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 127. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 128. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 129. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 142. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 143. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 144. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 145. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 227. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 230. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 231. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 232. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 233. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 234. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 235. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 236. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 237. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 245. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 248. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 249. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 250. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 251. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 252. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 253. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 254. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 255. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 281. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 284. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 285. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 286. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 287. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 288. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 289. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 290. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 291. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 292. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 293. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 298. ITALY BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 299. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 302. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 303. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 304. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 305. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 306. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 307. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 308. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 309. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 310. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 311. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 316. SPAIN BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bio-based Isododecane market report include:
  • Evonik Industries AG
  • Croda International Plc
  • Clariant AG
  • Dow Inc.
  • BASF SE
  • Solvay S.A.
  • Inolex Chemical Company
  • Arkema S.A.
  • Koster Keunen, Inc.
  • Symrise AG